Hidradenitis Suppurativa. Response to Treatment With Infliximab

Statistics

Original articles

Hidrosadenitis Supurativa. Respuesta al Tratamiento con Infliximab

J. Pedraz

Corresponding author

javierpedraz@aedv.es

Correspondence: Servicio de Dermatología, Hospital Universitario de la Princesa. Diego de León, 62. 28006 Madrid. Spain.

, E. Daudén, S. Pérez-Gala, R. Goiriz-Valdés, P. Fernández-Peñas, A. García-Diez

Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain

Read

8778

Times
was read the article

3725

Total PDF

5053

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/S1578-2190(07)70456-0

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	97	27	124
2025 5	103	39	142
2025 4	98	46	144
2025 3	94	31	125
2025 2	95	38	133
2025 1	82	36	118
2024 12	73	25	98
2024 11	71	61	132
2024 10	61	34	95
2024 9	74	42	116
2024 8	106	57	163
2024 7	68	60	128
2024 6	90	43	133
2024 5	59	30	89
2024 4	59	52	111
2024 3	61	41	102
2024 2	48	30	78
2024 1	38	43	81
2023 12	44	28	72
2023 11	46	33	79
2023 10	38	22	60
2023 9	45	19	64
2023 8	31	26	57
2023 7	32	41	73
2023 6	43	24	67
2023 5	26	26	52
2023 4	35	25	60
2023 3	23	24	47
2023 2	33	24	57
2023 1	50	32	82
2022 12	48	46	94
2022 11	29	33	62
2022 10	23	29	52
2022 9	25	56	81
2022 8	29	45	74
2022 7	18	35	53
2022 6	23	39	62
2022 5	36	43	79
2022 4	56	40	96
2022 3	40	56	96
2022 2	54	25	79
2022 1	30	36	66
2021 12	30	32	62
2021 11	48	45	93
2021 10	48	43	91
2021 9	46	41	87
2021 8	45	25	70
2021 7	42	29	71
2021 6	44	31	75
2021 5	38	36	74
2021 4	90	72	162
2021 3	64	31	95
2021 2	62	24	86
2021 1	42	18	60
2020 12	47	17	64
2020 11	26	22	48
2020 10	37	14	51
2020 9	40	20	60
2020 8	38	29	67
2020 7	40	12	52
2020 6	50	34	84
2020 5	73	26	99
2020 4	41	13	54
2020 3	41	21	62
2020 2	7	3	10
2020 1	1	9	10
2019 12	0	13	13
2019 11	0	8	8
2019 10	0	11	11
2019 9	0	13	13
2019 8	0	14	14
2019 7	0	17	17
2019 6	0	14	14
2019 5	0	56	56
2019 4	0	12	12
2019 3	0	6	6
2019 2	0	4	4
2019 1	0	6	6
2018 12	0	9	9
2018 8	0	3	3
2018 7	0	2	2
2018 6	0	3	3
2018 5	0	11	11
2018 3	0	10	10
2018 2	10	12	22
2018 1	21	15	36
2017 12	26	23	49
2017 11	29	25	54
2017 10	19	19	38
2017 9	27	11	38
2017 8	45	31	76
2017 7	44	9	53
2017 6	38	28	66
2017 5	58	19	77
2017 4	51	14	65
2017 3	38	17	55
2017 2	34	18	52
2017 1	39	17	56
2016 12	52	25	77
2016 11	39	13	52
2016 10	43	23	66
2016 9	45	34	79
2016 8	59	40	99
2016 7	51	22	73
2016 6	13	26	39
2016 5	4	11	15
2016 4	9	9	18
2016 3	5	6	11
2016 2	9	1	10
2016 1	6	3	9
2015 12	8	7	15
2015 11	15	11	26
2015 10	9	2	11
2015 9	5	1	6
2015 8	11	6	17
2015 7	18	15	33
2015 6	21	21	42
2015 5	53	18	71
2015 4	31	11	42
2015 3	25	5	30
2015 2	17	10	27
2015 1	23	21	44
2014 12	19	19	38
2014 11	14	13	27
2014 10	23	12	35
2014 9	28	12	40
2014 8	40	17	57
2014 7	53	12	65
2014 6	34	16	50
2014 5	35	20	55
2014 4	45	15	60
2014 3	40	25	65
2014 2	15	41	56
2014 1	29	32	61
2013 12	37	31	68
2013 11	28	33	61
2013 10	23	37	60
2013 9	32	22	54
2013 8	15	68	83
2013 7	40	75	115
2013 6	26	61	87
2013 5	29	49	78
2013 4	33	52	85
2013 3	32	40	72
2013 2	39	16	55
2013 1	20	7	27

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter